Ankur Shah
InvestorVice President, CCD at Abingworth
About
Ankur Shah joined Abingworth in October 2024, working with the transatlantic investment team with a focus on Clinical Co-Development, evaluating new opportunities and supporting existing investments. He previously served as a Senior Associate at NovaQuest Capital Management, Manager of Corporate Development at Boston Pharmaceuticals, and a Senior Associate at Artisan Healthcare Consulting. He holds a BS in Biomedical Engineering from the University of Connecticut.
Invests in
Biotech
Colleagues at Abingworth
Alex Asquith
Counsel at Abingworth
Andrew Sinclair
Managing Director, Head of Publics & Late Stage at Abingworth
Anna Slezak
Senior Associate at Abingworth
Bali Muralidhar
Global Head of Life Sciences & CIO at Abingworth
Carlos Paya
Venture Partner at Abingworth
Dayle Hogg
Operating Executive at Abingworth
Diya Malhotra
Principal at Abingworth
Elizabeth O'Brien
Executive Assistant at Abingworth